Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

Survival in Patients with Primary Pulmonary Hypertension

1991 • 3,369 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

1985 • 2,042 citations

Primary Pulmonary Hypertension

1987 • 2,027 citations

Primary Pulmonary Hypertension

1997 • 1,748 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Survival in Primary Pulmonary Hypertension

2002 • 1,192 citations

Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension

2000 • 1,129 citations

Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

1998 • 674 citations

Littérature commentée

1996 • 431 citations

Survival in primary pulmonary hypertension. Validation of a prognostic equation.

1994 • 368 citations

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.

1982 • 314 citations

Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion

1997 • 307 citations

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1995 • 303 citations

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension

1998 • 286 citations

Pulmonary Edema Complicating Continuous Intravenous Prostacyclin in Pulmonary Capillary Hemangiomatosis

1998 • 181 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study

2002 • 134 citations

Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.

1995 • 128 citations

Prostaglandins Induce Vascular Endothelial Growth Factor in a Human Monocytic Cell Line and Rat Lungs via cAMP

1997 • 127 citations

Pulmonary Artery Pressure–Flow Relations after Prostacyclin in Primary Pulmonary Hypertension

2002 • 106 citations

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension

1996 • 104 citations

Primary Pulmonary Hypertension

1994 • 65 citations

Clinical Insights Into the Pathogenesis of Primary Pulmonary Hypertension

1998 • 55 citations